What is true regarding leiomyoma (a type of benign tumor) of the esophagus (oesophagus)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Characteristics of Esophageal Leiomyoma

Esophageal leiomyoma commonly presents with dysphagia, is typically solitary, occurs more frequently in the lower third of the esophagus, and is not usually diagnosed with endoscopic biopsy alone. 1

Epidemiology and Presentation

  • Leiomyomas are the most common benign tumors of the esophagus, accounting for approximately 4% of all esophageal tumors 2
  • They are more common in males than females 1, 3
  • Typically present as solitary lesions rather than multiple tumors 3
  • Most commonly located in the middle or lower third of the esophagus 3
  • Dysphagia is the most common presenting symptom, especially when tumors exceed 5 cm in size 4, 3
  • Other symptoms may include:
    • Epigastric pain 4
    • Occasional dyspnea (in cases of large tumors causing compression) 5
    • Vomiting 3
    • Weight loss in some cases 5

Diagnostic Approach

  • Endoscopic ultrasound (EUS) with fine needle aspiration/biopsy (FNA/FNB) is the preferred diagnostic method for subepithelial lesions 1
  • On EUS, leiomyomas appear as hypoechoic, well-circumscribed masses arising from either:
    • Muscularis propria (4th layer)
    • Muscularis mucosae (2nd layer) 6
  • Standard endoscopic biopsy is usually inadequate for diagnosis as leiomyomas are submucosal/intramural tumors 1
  • Histological diagnosis requires specialized tissue sampling techniques:
    • Immunohistochemistry shows positive staining for smooth muscle actin and desmin
    • Negative staining for CD117, CD34, and S100 (distinguishing from GISTs) 1

Management

  • Asymptomatic leiomyomas <5 cm: observation is recommended 1
  • Symptomatic or >5 cm leiomyomas: surgical enucleation is indicated 1, 4
  • Surgical approach depends on tumor location:
    • Upper/middle third: right-sided video-assisted thoracoscopic surgery (VATS)
    • Lower third: left-sided VATS or laparoscopic approach 1
  • For giant leiomyomas (>10 cm), more extensive surgery may be required:
    • Esophagectomy may be necessary in cases with large defects after enucleation 5

Clinical Pearls and Pitfalls

  • Differentiation from gastrointestinal stromal tumors (GISTs) is crucial as management differs significantly 1
  • Leiomyomas are true smooth muscle tumors and are benign, while GISTs have malignant potential 6, 1
  • Even asymptomatic leiomyomas should be monitored with periodic endoscopic surveillance 1
  • Surgical enucleation without opening the mucosa is preferred when possible, as it is easier, faster, and safer compared to resection 4

In summary, esophageal leiomyomas are characterized by their presentation with dysphagia, solitary nature, predominant location in the lower esophagus, and requirement for specialized diagnostic techniques beyond standard endoscopic biopsy.

References

Guideline

Management of Esophageal and Gastric Leiomyomas

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Giant leiomyoma of the esophagus.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2002

Research

Leiomyoma of the esophagus: A case report and review of the literature.

International journal of surgery case reports, 2022

Research

Leiomyoma of esophagus-A case report.

International journal of surgery case reports, 2020

Research

Giant Esophageal Leiomyoma: Diagnostic and Therapeutic Challenges.

The American journal of case reports, 2021

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.